FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2051280592> ?p ?o ?g. }

• W2051280592 endingPage "296" @default.
• W2051280592 startingPage "288" @default.
• W2051280592 abstract "In Brief Objective: The aim of this study was to evaluate whether intratumoral human equilibrative nucleoside transporter 1 (hENT1) expression can predict the survival of advanced cholangiocarcinoma patients treated with adjuvant gemcitabine-based chemotherapy (AGC) after surgical resection. Background: There have been no reports concerning a useful predictive biomarker in patients with cholangiocarcinoma treated with adjuvant gemcitabine chemotherapy. Methods: Intratumoral hENT1 expression was investigated immunohistochemically in 105 patients with resected advanced cholangiocarcinoma. Relationships between intratumoral hENT1 expression and clinicopathological factors were evaluated by univariate and multivariate analyses. This study was a retrospective analysis on retrospectively collected tissue and data. Results: Fifty-one patients received AGC, and 54 did not. High and low intratumoral hENT1 expression was found in 74 (70%) and 31 patients (30%), respectively. There were no significant differences in clinicopathological factors between patients with high hENT1 expression and those with low hENT1 expression. Survival patients with high hENT1 expression were significantly better than those with low hENT1 expression among patients who received AGC (P = 0.008), but not among patients who did not (P = 0.894). Moreover, a significant difference in survival between patients who received AGC and those who did not was observed among patients with high hENT1 expression (P = 0.002), but not among patients with low hENT1 expression (P = 0.525). Intratumoral hENT1 expression was only an independent predictive factor for patients treated with AGC by multivariate analysis (P = 0.027). Conclusions: Intratumoral hENT1 expression may be a potent predictive marker for advanced cholangiocarcinoma patients treated with AGC. Intratumoral human equilibrative nucleoside transporter 1 (hENT1) expression was investigated immunohistochemically in tissue from 105 patients with resected advanced cholangiocarcinoma and identified as an independent predictive factor for those given adjuvant gemcitabine-based chemotherapy (AGC). Intratumoral hENT1 expression may be an important predictive biomarker for advanced cholangiocarcinoma patients receiving AGC." @default.
• W2051280592 created "2016-06-24" @default.
• W2051280592 creator A5010753152 @default.
• W2051280592 creator A5016890878 @default.
• W2051280592 creator A5019321525 @default.
• W2051280592 creator A5034493951 @default.
• W2051280592 creator A5041829691 @default.
• W2051280592 creator A5078155870 @default.
• W2051280592 creator A5091178168 @default.
• W2051280592 date "2012-08-01" @default.
• W2051280592 modified "2023-10-16" @default.
• W2051280592 title "Human Equilibrative Nucleoside Transporter 1 Expression Predicts Survival of Advanced Cholangiocarcinoma Patients Treated With Gemcitabine-Based Adjuvant Chemotherapy After Surgical Resection" @default.
• W2051280592 cites W1931508686 @default.
• W2051280592 cites W1968323734 @default.
• W2051280592 cites W1980948970 @default.
• W2051280592 cites W1982293352 @default.
• W2051280592 cites W1999437680 @default.
• W2051280592 cites W2005761961 @default.
• W2051280592 cites W2005961536 @default.
• W2051280592 cites W2018319091 @default.
• W2051280592 cites W2043157852 @default.
• W2051280592 cites W2054131554 @default.
• W2051280592 cites W2063226474 @default.
• W2051280592 cites W2075539186 @default.
• W2051280592 cites W2077902459 @default.
• W2051280592 cites W2080048596 @default.
• W2051280592 cites W2086275648 @default.
• W2051280592 cites W2086686513 @default.
• W2051280592 cites W2087336559 @default.
• W2051280592 cites W2100388782 @default.
• W2051280592 cites W2100780413 @default.
• W2051280592 cites W2103437429 @default.
• W2051280592 cites W2113183935 @default.
• W2051280592 cites W2114449958 @default.
• W2051280592 cites W2115261608 @default.
• W2051280592 cites W2129051737 @default.
• W2051280592 cites W2129197203 @default.
• W2051280592 cites W2131025996 @default.
• W2051280592 cites W2131555383 @default.
• W2051280592 cites W2145833871 @default.
• W2051280592 cites W2158734599 @default.
• W2051280592 cites W2166418422 @default.
• W2051280592 cites W2167363380 @default.
• W2051280592 cites W2188928518 @default.
• W2051280592 doi "https://doi.org/10.1097/sla.0b013e3182536a42" @default.
• W2051280592 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22580938" @default.
• W2051280592 hasPublicationYear "2012" @default.
• W2051280592 type Work @default.
• W2051280592 sameAs 2051280592 @default.
• W2051280592 citedByCount "38" @default.
• W2051280592 countsByYear W20512805922012 @default.
• W2051280592 countsByYear W20512805922013 @default.
• W2051280592 countsByYear W20512805922014 @default.
• W2051280592 countsByYear W20512805922015 @default.
• W2051280592 countsByYear W20512805922016 @default.
• W2051280592 countsByYear W20512805922017 @default.
• W2051280592 countsByYear W20512805922018 @default.
• W2051280592 countsByYear W20512805922019 @default.
• W2051280592 countsByYear W20512805922022 @default.
• W2051280592 crossrefType "journal-article" @default.
• W2051280592 hasAuthorship W2051280592A5010753152 @default.
• W2051280592 hasAuthorship W2051280592A5016890878 @default.
• W2051280592 hasAuthorship W2051280592A5019321525 @default.
• W2051280592 hasAuthorship W2051280592A5034493951 @default.
• W2051280592 hasAuthorship W2051280592A5041829691 @default.
• W2051280592 hasAuthorship W2051280592A5078155870 @default.
• W2051280592 hasAuthorship W2051280592A5091178168 @default.
• W2051280592 hasConcept C126322002 @default.
• W2051280592 hasConcept C143998085 @default.
• W2051280592 hasConcept C144301174 @default.
• W2051280592 hasConcept C167135981 @default.
• W2051280592 hasConcept C185592680 @default.
• W2051280592 hasConcept C204232928 @default.
• W2051280592 hasConcept C2776694085 @default.
• W2051280592 hasConcept C2777844706 @default.
• W2051280592 hasConcept C2777863537 @default.
• W2051280592 hasConcept C2780258809 @default.
• W2051280592 hasConcept C2781197716 @default.
• W2051280592 hasConcept C38180746 @default.
• W2051280592 hasConcept C55493867 @default.
• W2051280592 hasConcept C71924100 @default.
• W2051280592 hasConcept C90924648 @default.
• W2051280592 hasConceptScore W2051280592C126322002 @default.
• W2051280592 hasConceptScore W2051280592C143998085 @default.
• W2051280592 hasConceptScore W2051280592C144301174 @default.
• W2051280592 hasConceptScore W2051280592C167135981 @default.
• W2051280592 hasConceptScore W2051280592C185592680 @default.
• W2051280592 hasConceptScore W2051280592C204232928 @default.
• W2051280592 hasConceptScore W2051280592C2776694085 @default.
• W2051280592 hasConceptScore W2051280592C2777844706 @default.
• W2051280592 hasConceptScore W2051280592C2777863537 @default.
• W2051280592 hasConceptScore W2051280592C2780258809 @default.
• W2051280592 hasConceptScore W2051280592C2781197716 @default.
• W2051280592 hasConceptScore W2051280592C38180746 @default.
• W2051280592 hasConceptScore W2051280592C55493867 @default.
• W2051280592 hasConceptScore W2051280592C71924100 @default.
• W2051280592 hasConceptScore W2051280592C90924648 @default.
• W2051280592 hasIssue "2" @default.

• next